on The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Stake in Life Science REIT plc
The Vanguard Group, Inc. has released Form 8.3, revealing its public opening positions in Life Science REIT plc. As of February 19, 2026, Vanguard holds 3,269,509 of the 1p ordinary shares in Life Science REIT, representing 0.93% of the relevant securities.
This disclosure is in line with Rule 8.3 of the Takeover Code, necessitating declarations from parties holding an interest of 1% or more in relevant securities. The document also indicates dealings with British Land Company plc in connection with the offer.
Vanguard's latest dealing involved the purchase of 5,620 ordinary shares at £0.43 per unit. No cash or stock-settled derivatives were reported. Furthermore, no indemnities, options, or derivative agreements were noted in relation to Life Science REIT.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news